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S u m m a r y 
 
Peripheral nerve injury is a common casualty and although peripheral nerve fibers retain a considerable 
regeneration potential also in the adult, recovery is usually rather poor, especially in case of large nerve 
defects. The aim of this paper is to address the perspectives in regeneration and tissue engineering after 
peripheral nerve injury by reviewing the relevant experimental studies in animal models. After a brief 
overview of the morphological changes related to peripheral nerve injury and regeneration, the paper will 
address the evolution of peripheral nerve tissue engineering with special focus on transplantation 
strategies, from organs and tissues to cells and genes, that can be carried out, particularly in case of 
severe nerve lesions with substance loss. Finally, the need for integrated research which goes beyond 
therapeutic strategies based on single approaches is emphasized, and the importance of bringing together 
the various complimentary disciplines which can contribute to the definition of effective new strategies for 
regenerating the injured peripheral nerve is outlined. 
 
 
1.  Introduction 
 
Peripheral nerves are the organs which constitute the main part of the peripheral nervous system. They 
are made by fascicles of myelinated and unmyelinated nerve fibers (i.e. axons surrounded by glial 
ensheathings which represent the parenchyma of the organ) and by a complex stromal connective scaffold 
(Geuna et al., 2009). Peripheral nerves can also be named as nerves only since nerve fiber fascicles in the 
central nervous system are referred to as white matter (and not central nerves). By contrast, the term 
nerve fiber is used to refer both to central and peripheral axo-glial com-plexes and thus the type of nerve 
fiber must be always specified (either central or peripheral). 
 
Nerves constitute a very rich web throughout the body and con-nect the central nervous system and the 
sensory and autonomic ganglia to the peripheral target organs of the motor and sensory pathways 
(Williams, 1999). The large extension of these organs makes them potentially affected by traumas in any 
site of the body. Peripheral nerve lesions are much more frequent than spinal cord lesions and their high 
incidence is at the basis of the continuously increasing interest of both basic and clinical researchers to the 
study on nerve repair and regeneration (Evans, 2001; Ruijs et al., 2005; Siemionow and Brzezicki, 2009). 
Nerve lesions do not usu-ally represent a threat for the patient’s life but almost always affect the patient’s 
quality of life which represents one of the main health targets of today’s medicine (Battiston et al., 2009b). 
 
In comparison to the central nervous system, nerve fibers in the peripheral nervous system retain, also 
in adulthood, a higher posttraumatic regeneration potential. However, in most cases, the clinical outcome 
after peripheral nerve lesions is far from being sat-isfactory and almost never functional recovery is 
complete (Höke, 2006; Lundborg, 2002; Midha, 2006; Millesi, 2006; Ruijs et al., 2005; Samii et al., 1997; 
Casha et al., 2008; Battiston et al., 2009b). There is thus a need for more research in nerve repair and 
regen-eration which brings together different disciplines which might contribute, not only to increase our 
knowledge about the biological mechanisms that underlie the complex sequence of events which follows 
nerve injury, but also to define the best strategies for opti-mizing posttraumatic nerve regeneration and, 
eventually, the full recovery of the patient’s motor and sensory function (Siemionow and Brzezicki, 2009). 
 
In the present review, we will first briefly outline the sequence of morphological events which follow a 
nerve lesion and then we will overview some of the most promising strategies that are cur-rently being 
explored in experimental animal models to improve posttraumatic nerve regeneration. 
 
2.  Nerve injury and regeneration 
 
The most popular classification of nerve injuries is still undoubt-fully the Sunderland’s scale which 
includes five degrees which correspond to an increasing severeness of the lesion ( Sunderland, 1951). The 
first-degree (also called neuropraxia) refers to injuries (usually compressions) that cause a block in the 
action potential conduction without loosing axonal continuity. In second-degree injuries, axonal continuity is 
lost without damage of the surround-ing glial and connective structures; thus, axonal regrowth and its 
proper orientation is optimal being guided by the original glial tubules in the distal nerve stump. In third-
degree injuries, also the endoneurial structures are disrupted and thus, although nerve continuity is 
maintained, regrowth of damaged axons and espe-cially their orientation to the proper target can be poorer 
than in second-degree lesions. Sundenrland’s four-degree refers to nerve injuries which cause the 
disruption of all nerve fibers and support-ing structures (endoneurium and perineurium) but the epineurium. 
Although nerve continuity is maintained, and thus regeneration can occur spontaneously, nerve recovery 
might be poor due to scar tis-sue formation and mis-orientation of regenerated axons. Finally, in fifth-
degree injuries, complete nerve transection occurs leading to the impossibility to get axonal regeneration 
unless nerve continuity is reconstructed surgically. In 1988, MacKinnon and Dellon pro-posed a sixth-
degree to Sunderland’s original classification which refers to complex nerve lesions where a combination of 
different degrees of injury takes place. 
 
After injury, morphological changes occur not only at the injury site but also proximally and distally to it. 
Changes occurring in the soma of both motor and sensory neurons are related to a switch from a 
“signalling mode” to a “growing mode” (Fu and Gordon, 1997) with important changes in the synthesis of 
various proteins such as growth-associated proteins (Schreyer and Skene, 1991; Tetzlaff et al., 1991), 
cytoskeletal proteins (Fornaro et al., 2008) and neuropeptides (Hökfelt et al., 1994). 
 
The proximal tract of the transacted nerve fibers shows a partial retrograde axon degeneration over few 
internodal segments with formation of bands of Büngner similar to those detectable in the distal nerve 
stump (Cajal, 1928). After an initial delay of few hours ( Sunderland, 1978), a rich terminal sprouting occurs 
from the tip of proximal axon stumps. The regenerating sprouts grow up along the proximal bands of 
Büngner, across the injury site and finally along the distal bands of Büngner (Mira, 1984; Fawcett and 
Keynes, 1990; Witzel and Brushart, 2003). In the distal nerve segment a peculiar process, known as 
Wallerian degeneration (Stoll and Müller, 1999), starts immediately after injury. Wallerian degeneration is 
charac-terized by myelin breakdown, proliferation of Schwann cells and recruitment of macrophages. 
Disintegration of axoplasmic micro-tubules and neurofilaments by proteolysis starts within the first few days 
(Vial, 1958; Schlaepfer, 1977; Lubinska,´ 1982). The loss of axon–Schwann cell contact is a signal that 
induces proliferation of Schwann cells and upregulation of several types of neurotrophic factors, such as 
NGF (Heumann, 1987; Thoenen et al., 1988), BDNF, NT-3, NT-4/5, and NT-6 (Funakoshi et al., 1993), and 
the glial growth factor neuregulin (Audisio et al., 2008). 
 
One of the most peculiar morphological changes in Wallerian degeneration is the formation of columns 
of Schwann cells (named bands of Büngner) which guide the regenerating axons with their basal 
membranes and neurite outgrowth-promoting factors, such as laminin and fibronectin (Baron-Van 
Evercooren et al., 1982; Liu, 1996; Hall, 1997). It has been shown that an excess number of axonal sprouts 
regenerate along the bands of Büngner (Sanders and Young, 1946; Aguayo et al., 1973) and thus their 
initial number detectable in the distal nerve segment usually exceed the number in the proximal nerve 
segment (Povlsen and Hildebrand, 1993). With time, a pruning process takes place and only regenerated 
axons that have reached a proper distal target survive (Sanders and Young, 1946), while the other axons 
degenerate (Griffin and Hoffman, 1993). Yet, a morphological change typical of regenerated nerves that 
was already pointed out by Cajal (1928), is “compart-mentation” (Morris et al., 1972, Lundborg, 2004), i.e. 
the formation of “minifascicles” in the distal nerve stump which replace the orig-inal large fascicles and 
make it possible to recognize a regenerated nerve even long time after injury. 
  
3.  Tissue engineering of peripheral nerves 
 
It is beyond the aims of this paper to address the issue of the clinical indications of nerve surgery. 
Clearly, severe neurotmesis lesions with interruption of epineurial continuity require surgical reconstruction 
which is usually represented by direct nerve suture of the two stumps (end-to-end neurorrhaphy). When a 
nerve defect occurs, direct “tension” suture is harmful (Yi and Dahlin, 2010) and a guide must be used to 
bridge the gap (Millesi, 1970). The nerve guide is usually taken from the same patient’s sural nerve. 
Although autologous grafting causes a slight donor site mobility, it must be clearly pointed out that, today, it 
is still the gold stan-dard of nerve gap reconstruction in the clinics (Battiston et al., 2009a,b; Siemionow 
and Brzezicki, 2009). However, in order to avoid donor site morbility, an artificial nerve guide could be used 
to bridge the gap, especially if the gap is small and in sensory nerves; this approach is usually referred to 
as tubulization (Battiston et al., 2005; Geuna et al., 2007). Yet, peripheral nerve surgeons are also very 
interested in the development of artificial nerve grafts due to the fact that in severe and/or multiple nerve 
lesions (like in brachial plexus injury) there is often a limit of donor nerves. Unfortunately, up to now, except 
for simple tubular implants (Kehoe et al., in press), no bioengineered artificial nerve has been used for sup-
porting axon elongation in order to bridge critical peripheral nerve defects in humans. 
 
The first attempts to reconstruct peripheral nerves were already described by Galen in the second 
century A.D. (Terzis et al., 1997; Naff and Ecklund, 2001; Battiston et al., 2009a) and were followed, over 
the centuries, by other sporadic descriptions of nerve sutures such as those reported by Paul von Aegina 
in the seventh century (Streppel et al., 2000), Rahzes and Avicenna in the ninth century ( Sunderland, 
1981), Guglielmo di Saliceto, Guido Lanfranchi, Guy de Chauliac, Leonardo di Bertapaglia (Ladenheim, 
1989; Terzis et al., 1997), and Gabriele Ferrara (cited in Artico et al., 1996) who was the first to provide a 
comprehensive description of nerve the suture procedure. Along the second part of nineteen century, 
based on the milestone basic science observations of Augustus Waller (1850) (reprinted in Stoll et al., 
2002), nerve reconstruction saw major advancements leading to the first attempts of nerve tissue engi-
neering. Philipeaux and Vulpian (1870) and Albert, 1885 were the first to describe the repair of nerve 
defects by means of autologous nerve segments. Few years later, Neuber (1879), Glück (1880) and 
Vanlair (1882), described a method for nerve repair based on the employment of another tissue (biological 
tubulization), namely a piece of bone. Biological tubulization has received much attention over the last 
century and the best results have been obtained using veins and skeletal muscle tissue (Chiu and Strauch, 
1990; Pereira et al., 1991; Geuna et al., 2004; Tos et al., 2007). Also the use of a non biological conduit for 
nerve repair (synthetic tubulization), a strat-egy that was first attempted by Payr already in 1900, has 
recently seen a tremendous development due to the potential commercial spin-off of biomaterials for 
clinical applications (Luis et al., 2007; Siemionow et al., 2010). 
 
Over recent years, transplantation is acquiring more and more importance in surgery, moving from 
whole organ transplants to transplantation of only parts of an organ (tissues and cells), thus 
 
expanding the employment of autotransplantation which avoids the problems related to rejection. In 
particular, for peripheral nerve reconstruction a great attention among researchers has been attracted by 
autologous cell transplantation therapies (Tohill and Terenghi, 2004; Pfister et al., 2007). Of course, the 
choice of the cell type to be used for transplantation is the key factor for the therapeutic success and 
various types of cells have been shown to promote axonal regeneration after their transplantation inside 
nerve conduits (Siemionow and Brzezicki, 2009). One of the most promising approaches is represented by 
glial cell transplantation since these cells are known to play a major role in axonal regen-eration by 
secreting neurotrophic factors and participating in the myelinic and amyelinic ensheathing of regenerated 
axons (Radtke and Vogt, 2009). Two types of gial cells have received much atten-tion so far: Schwann 
cells (SCs), which represent the glia of most peripheral nerves, and olfactory ensheathing cells (OECs), 
which are the glia of the olfactory nerve. 
 
SCs, besides ensheathing peripheral nerve axons, also secrete growth factors considered essential for 
the survival of the neuronal cells and the promotion of the regeneration process (Hall, 2001). After 
peripheral nerve injury, SCs together with macrophages, remove necrotic tissue and myelin debris. 
Furthermore, SCs pro-liferate to form Büngner bands, which help the regrowing axons to elongate their 
growth cones in the direction of denervated targets (Geuna et al., 2009). During nerve regeneration SCs 
create a suit-able environment for axonal growth by expressing cell-adhesion molecules and forming an 
endoneurial sheath that acts as a guide for regenerating axons. Because of their crucial involvement in the 
regeneration of injured peripheral nerves, the attempts to use SCs to enrich the nerve conduits are 
continuously increasing. Hadlock et al. (2000) and Mosahebi et al. (2001) showed, in the rat, that SC 
transplantation inside different types of nerve conduit leads to the improvement of both quality and rate of 
axon regeneration. SC-seeded vein conduits proved also to be effective, in the rabbit, in bridging long 
nerve defects up to 4 cm (Zhang et al., 2002) and 6 cm (Strauch et al., 2001), whereas the use of the vein 
conduit alone in the same experimental conditions was ineffective. 
 
Recently Goto et al. (2010) studied in vitro the efficiency of a new approach for the repair of the injured 
peripheral nerve based on cultures of SCs on a rolled sheet of collagen gel and showed that this construct 
kept the viability of SCs and promoted axonal outgrowth. 
 
Whereas several experimental animal studies showed the effec-tiveness of SC transplantation to 
promote nerve regeneration, Mosahebi et al. (2001) pointed out that the use of autologous cul-tured SCs 
may be impractical for the treatment of acute nerve injuries in the clinics because of the time required for 
harvest-ing and expanding SCs; actually, up to 10 weeks of SC culture may be required to get a sufficient 
amount of cells. Yet, isola-tion of SCs is complicated because of the frequent contamination of fibroblasts 
(Mosahebi et al., 2001). In order to cope with the latter problem, Wei et al. (2009) adopted a new 
purification tech-nique of rat SCs which is based on the removal of contaminating fibroblasts by means of a 
combination of Ara-C (cytosine-B arabi-noside hydrochloride) and a differential cell detachment technique, 
a method which may give rise to a stable SC yield with a final purity above 99.2% within 10 days. 
 
Recently, olfactory ensheathing cells (OECs) withdrawn from the olfactory nerve have raised great 
interest for neural repair purposes because of their homing capacity in both peripheral and central nervous 
system. OECs, which guide the continuously regenerating axons of the olfactory neuroepithelium towards 
the olfactory bulb, have shown to retain a higher migratory potential and ability to penetrate glial scars in 
comparison to SCs (Franklin and Barnett, 1997), a property which makes them a rational trans-plantation 
candidate for nerve reconstruction. The employment  
of OEC transplantation in injured peripheral nerves have shown that, in rodents, these cells can provide 
trophic support, form cel-lular bridges across the site of injury, and significantly promote axonal 
regeneration (Verdú et al., 1999; Guntinas-Lichius et al., 2001; Radtke et al., 2005, 2010;  Dombrowski et 
al., 2006). 
 
Transplantation of OECs (Radtke et al., 2005;  Dombrowski et al., 2006) into the regenerating sciatic 
nerve of rodents showed that OECs survived, distributed longitudinally across the lesion site and were 
integrated into the repaired nerves, contributing to the myelin formation of regenerated axons. These 
authors hypothe-sized that, after lesion, transplanted OECs are primed to produce neurotrophins and, 
therefore, can have an immediate effect on the injured axons before scar formation occurs. Thus, it can be 
hypothetically tenable that OEC transplantation at the time of microsurgical repair of peripheral nerves may 
provide a scaffold for axons to regenerate as well as trophic support and directional cues leading to 
increased axonal regeneration across the repair site and improved functional outcome (Radtke and Vogt, 
2009). 
 
So far, OECs have been mainly obtained from primary cultures. Like all primary cell cultures, their 
preparation has various dis-advantages, such as labor-intensive operator workload, small cell amount, 
other cell-type contamination (especially fibroblasts and astrocytes) and limited survival in culture (DeLucia 
et al., 2003; Moreno-Flores et al., 2006). In alternative to primary glial cell cultures, immortalized clonal cell 
lines have been proposed for experimental animal studies (Lakatos et al., 2000; DeLucia et al., 2003). 
Goodman et al. (1993) described an immortalized cell line 
 
– named Neonatal Olfactory Bulb Ensheathing Cell (NOBEC) – that was derived from neonatal OECs by 
transduction with SV40 large T cell antigen. It has been shown that NOBECs, though immor-talized, are 
minimally transformed, maintain viable monolayers without forming tumors when transplanted into rats and 
have a low proliferation rate in comparison to glioma cells (Goodman et al., 1993). NOBECs produce the 
same growth-promoting proteins as primary OEC cultures (Goodman et al., 1993), possess regeneration-
promoting capabilities, and retain the major glial features (Audisio et al., 2009). 
 
Since the relatively small amount of glial cells that can be obtained from primary cultures is considered a 
limitation for clini-cal applications (Mosahebi et al., 2001), the use of stem cells that can be differentiated in 
glial cells in vitro before transplantation, have also been investigated. Neural stem cells (NSCs) have been 
tested for nerve regeneration purposes in animal models since they have the potential to differentiate into 
both neurons and glia (Bithell and Williams, 2005). 
 
Murakami et al. (2003) have used a silicone tube enriched with transplanted NSCs for repairing rat nerve 
defects and found that this approach promote axonal regeneration. Transplantation of NSCs were also 
found to promote axonal regeneration after chronical transection of rat nerves (Heine et al., 2004). 
 
Although the use of undifferentiated NSCs has led to good exper-imental results, it should be noted that 
tumor formation following NSC transplantation in a rat peripheral nerve injury model was reported thus 
pointing to the importance of comprehensive in vitro characterization of cells prior to transplantation for 
avoiding sub-clones which may become tumorogenic (Radtke et al., 2010). Yet, it should also be noted that 
in vitro NSC pre-differentiation before conduit enrichment did not lead to positive results in a rat neu-
rotmesis experimental model (Amado et al., 2008; Luís et al., 2008; Amado et al., 2010). 
 
In alternative to NSCs, mesenchymal stem cells (MSCs) have been widely investigated for improving 
peripheral nerve regen-eration. They can be easily obtained, purified and expanded in culture and offer a 
potentially unlimited source of cells for tissue engineering (Caplan and Dennis, 2006). They can be derived 
from various stem cell niches in adult tissues by means of minimally invasive approaches. Although bone 
marrow is the most charac-terized source of MSCs, numerous reports have demonstrated that MSCs can 
also be isolated from adipose tissue, fresh or banked human umbilical cord blood, and tooth pulp (Alhadlaq 
and Mao, 2004). 
 
Advances in stem cell biology and manipulation (Tohill and Terenghi, 2004) have opened new 
perspectives since MSCs are thought to be able to differentiate into multiple cell lineages, such as 
osteoblasts, chondrocytes, myoblasts, adipocytes, neuron-like cells and glial-like cells (Alhadlaq and Mao, 
2004; Raimondo et al., 2006; Mantovani et al., 2010). Yet, MSC capability of self-replication to many 
passages makes them potentially expandable to sufficient numbers for allowing regeneration of large 
tissue defects. 
 
Recently, Cho et al. (2010) showed that human MSCs can be differentiated into neural cells in vitro and, 
when transplanted in the injured facial nerve of the guinea pig, they were effective in promoting nerve 
regeneration. Moreover it has been shown that also SCs can be derived from rat MSCs (Kingham et al., 
2007). It has been shown that MSCs can differentiate into Schwann cell-like phenotype, with the 
morphological, molecular and functional char-acteristics of regenerative SCs, both in rat (Caddick et al., 
2006) and in human (Brohlin et al., 2009) thus opening interesting per-spectives in the clinical view since 
this approach may facilitate the availability of adequate quantity of autologous SCs from the same patient. 
It has also been shown that rat adipose-derived MSCs have potential to myelinate during regeneration 
(Mantovani et al., 2010). 
 
Cell transplantation however, is not the only pillar of tissue engi-neering and local delivery of growth 
factors and other molecules which can promote tissue repair is also emerging as one of the key issues in 
regenerative medicine. One of the most promising strategies for local growth factor delivery is probably 
gene trans-fer and this approach is also getting more and more interest in the repair of the peripheral 
nervous system (Haastert and Grothe, 2007; Tannemaat et al., 2009; Zacchigna and Giacca, 2009; Pereira 
Lopes et al., in press). Various studies in animal models have shown that peripheral nerve regeneration 
can be improved by gene trans-fer. For instance, it has been demonstrated that over-expression of FGF-2 
by transplanted SCs can improve length and number of regenerating axons after rat peripheral nerve repair 
(Timmer et al., 2003). Similar results were obtained by Haastert et al. (2006) who focused on the different 
effects of rat Schwann cell gene trans-fer with low and high molecular weight FGF-2 isoforms and find out 
that 18-kDa-FGF-2 mediated inhibitory effects on regenerating axons while 21-/23-kDa-FGF-2 induced 
early functional recovery and stimulation of myelination. 
 
 
4.  Improving regeneration after nerve reconstruction 
 
Tissue engineering of peripheral nerves not only relies on the development of innovative microsurgical 
techniques and/or trans-plantation strategies and devices, but also on the combined use of other 
therapeutic tools which can improve the effectiveness of nerve reconstruction. 
 
First, the possibility to manipulate the regeneration process by means of drug administration before, 
during and/or after nerve repair should be considered (Magnaghi et al., 2009). Unfortunately, in spite of the 
several experimental animal studies that showed the effectiveness of a number of molecules, such as 
hormones and drugs, for promoting nerve regeneration, there is no established treatment protocol for 
promoting nerve recovery after surgical reconstruction. 
 
Second, the possibility to improve the effectiveness of periph-eral nerve tissue engineering by means of 
physical therapy should also be taken into great account since many studies have shown that various 
physical agents applied during and after nerve recon-struction can significantly increase functional 
recovery. The most promising approaches, already tested in animal models, include electrical stimulation 
(Panetsos et al., 2008), manual stimulation (Bischoff et al., 2009), and photo-stimulation (Rochkind et al., 
2009). 
 
Finally, a particular mention deserves the need to investi-gate brain plasticity related to nerve tissue 
engineering, i.e. the adaptation changes occurring in the central nervous system as a consequence of 
peripheral nerve repair and regeneration (Navarro, 2009; Herrera-Rincon et al., 2010). While it is widely 
acknowl-edged that changes occurring after peripheral nerve injury and regeneration induce changes to 
the central motor and sensory pathways, unfortunately the large majority of nerve repair and regeneration 
studies in experimental animal models are exclu-sively based on the investigation of what happens at the 
lesion site and/or at the level of the distal nerve trunk. Central changes can occur at various cortical and 
sub-cortical stations along motor and sensory pathways and it can be foreseen that a better knowl-edge 
about brain plasticity mechanisms related to peripheral nerve tissue engineering might represent the basis 
for directing the development and validation of new and more effective treatment strategies. 
 
5. The importance of publishing negative results in nerve tissue engineering 
 
A very important issue in nerve tissue engineering is the pub-lication of negative results. Positive result 
bias is a well-known phenomenon in scientific literature ( Hasenboehler et al., 2007) the main reasons to 
be found in the unwillingness of researchers to publish negative results which are often, though 
erroneously, per-ceived as a scientific failure. 
 
In peripheral nerve regeneration studies, this occurrence might be even more pronounced for a couple 
of other reasons. First, the involvement of industrial companies, due to the frequent employment of 
biomaterials and/or stimulation devices, which might be unwilling of publishing a study that prospects a null 
or even negative effect of one of their products. Second, and perhaps most important, nerve regeneration 
studies are based experiments which take long time to be completed. Postoperative observa-tion may last 
for several months and thus results of one single experiment may require more than one year or more to 
get the preliminary results. When additional experiments are required (as it usually occurs) study’s duration 
may last very long and thus, if indications of the ineffectiveness (or negative effects) of a new therapeutic 
approach arise from the first experiments, researchers might decide to give up with the study rather than 
try to complete it and publish its results. However, it should be clearly pointed out that divulgation of 
negative results is very important since it avoids repetition of unsuccessful experiments and facilitate the 
concen-tration of the research resources on the most promising approaches for improving repair and 
regeneration of injured peripheral nerves. 
 
Finally, researchers, especially the youngest ones, might believe that there is a lack of interest among 
editors to accept in their jour-nals papers which report on negative results. Actually, this does not appear to 
be the case in the nerve regeneration research and, espe-cially in recent years, several papers have been 
published reporting negative results after various tissue engineering approaches in experimental animal 
models (Amado et al., 2008; Grosheva et al., 2008; Haastert et al., 2009; Sinis et al., 2008, 2009; Skouras 
et al., 2009). 
 
6.  Conclusions 
 
Unlike the adult central nervous system, where the potential for axonal growth and neurogenesis is very 
limited and plasticity (in response to stimulus) and regeneration (in response to injury) are mainly 
represented by adaptive changes in synaptic reorga-nization and neural circuitries, plasticity and 
regeneration in the adult peripheral nervous system are more pronounced and they are predominantly 
based on axonal re-growth and neuron addi-tion (Geuna et al., 2010). However, especially in case of 
severe nerve lesions with substance loss, regeneration and functional recovery are usually partial and 
often frankly unsatisfactory (Höke, 2006; Lundborg, 2002; Midha, 2006; Millesi, 2006; Ruijs et al., 2005; 
Samii et al., 1997; Casha et al., 2008; Battiston et al., 2009b) thus calling for more research which should 
strive for a new level of innovation which will bring together various different disciplines from basic to 
clinical. The recent scientific advances have clearly pointed out that peripheral nerve repair and 
regeneration cannot be any more a mat-ter of surgical reconstruction only, but should rather be addressed 
from multiple and interdisciplinary viewpoints (Battiston et al., 2009a,b). To say it in other words: In 
peripheral nerve injury, perfect microsurgical repair is just part of the story! 
 
In this review we have synthetically overviewed a huge body of literature which touches several scientific 
disciplines that are very different among them. The key discipline is of course recon-structive microsurgery 
and, in order to strengthen the translational approach, we believe that it is very important to emphasize that 
clinical scientists should be whenever possible involved not only at the end of the research (when basic 
science results appear to be ready to be tested for a clinical application) but also in the very early research 
steps (when basic science experiments are designed). In this way, clinicians can follow up the research in 
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